Covid-19 Research

Clinical Study

Non Inferiority Study to Prevent Hepatitis B Vertical Infection, Non Randomized Clinical Trial

Journal of Biomedical Research & Environmental Sciences article abstract with citation details, DOI, publication dates, subject areas, full text links, and references.

View DOI Submit Manuscript

Article Details

Publication record, authors, dates, abstract, and full text access.

Open Access
Article Type Clinical Study
Subject Medicine Group
OCLC 9501817594
Khaled Ali Abu Ali*
Issue: Volume3-Issue3
Pages: 316-319
Received: 2022-03-04
Accepted: 2022-03-30
Published: 2022-03-31

Abstract

Background: Hepatitis B is a vaccine-preventable liver infection caused by the Hepatitis B Virus (HBV). Hepatitis B (HB) is spread when blood, semen, or other body fluids from a person infected with the virus enters the body of someone who is not infected.

Aim of the study: To identify the efficacy of hepatitis B immunoglobulin with hepatitis B vaccine versus hepatitis B vaccine alone to prevent the HB vertical infection.

Method: An quasi-experimental clinical trial was used, 114 new born were included in the control group and 114 newborn were included in the intervention group, both groups were given HB vaccine but the control group HB vaccine combined with hepatitis B immunoglobulin, all of the subjects were born to mother positive HBV and negative HBeAg indicating inactive HBV cases.

Results: Revealed that the used regimens were effective to interrupt mother to child transmission of HBV, the geometric mean titration was higher (207.64 IU/L) among the infants were included in the control group versus (180.87 IU/L) to the infants were included in the intervention group, non-protective rate was 6.6%, relative risk 2.63.

Conclusion: Hepatitis B vaccine alone is not inferior to HB vaccine combined with HBIG to prevent the infection and both regimens were effective.

FullText HTML FullText PDF DOI: 10.37871/jbres1440 Crossmark

Certificate of Publication

Certificate of Publication

Copyright

© 2022 Abu Ali KA. Distributed under Creative Commons CC-BY 4.0 Creative CommonsAttribution

How to cite this article

Abu Ali KA. Non Inferiority Study to Prevent Hepatitis B Vertical Infection, Non Randomized Clinical Trial. J Biomed Res Environ Sci. 2022 Mar 31; 3(3): 316-319. doi: 10.37871/jbres1440, Article ID: JBRES1440, Available at: https://www.jelsciences.com/articles/jbres1440.pdf

Subject area(s)

Clinical Trials

References

  1. Viral Hepatitis, Division of Viral Hepatitis. Atlanta-USA: Center for Disease Control and Prevention. 2014.
  2. https://tinyurl.com/5n7h3dje
  3. What is hepatitis?. Geneva, World Health Organization. 2016.
  4. https://tinyurl.com/3ez8dtyv
  5. Chelsea B, Jennifer M, Benjamin C. Addressing the increasing global burden of viral Hepatitis. Hepatobiliary Surgery and Nutrition. 2017;6(4):274-276.
  6. https://tinyurl.com/tvjywrev
  7. Shepard CW, Simard EP, Finelli L, Fiore AE, Bell BP. Hepatitis B virus infection: Epidemiology and vaccination. Epidemiol Rev. 2006;28:112-25. doi: 10.1093/epirev/mxj009. Epub 2006 Jun 5. PMID: 16754644.
  8. Lai CL, Chien RN, Leung NW, Chang TT, Guan R, Tai DI, Ng KY, Wu PC, Dent JC, Barber J, Stephenson SL, Gray DF. A one-year trial of lamivudine for chronic hepatitis B. Asia Hepatitis Lamivudine Study Group. N Engl J Med. 1998 Jul 9;339(2):61-8. doi: 10.1056/NEJM199807093390201. PMID: 9654535.
  9. Dienstag JL. Hepatitis B virus infection. N Engl J Med. 2008 Oct 2;359(14):1486-500. doi: 10.1056/NEJMra0801644. Erratum in: N Engl J Med. 2010 Jul 15;363(3):298. PMID: 18832247.
  10. Kramvis A, Kew M, François G. Hepatitis B virus genotypes. Vaccine. 2005 Mar 31;23(19):2409-23. doi: 10.1016/j.vaccine.2004.10.045. PMID: 15752827.
  11. Hepatitis B, Fact sheet N° 204. Geneva, World Health Organization. 2015.
  12. https://tinyurl.com/yfnnzp66
  13. World Hepatitis Day. Geneva, World Health Organization. 2018.
  14. https://tinyurl.com/2p8mcuny
  15. Dheir M, Ghuneim N, Abu-Ali K. Annual epidemiological report Gaza strip, Ministry of Health. Palestine. 2012.
  16. https://tinyurl.com/2p8r8mhr
Publish with JBRES — Peer-reviewed, multidisciplinary Open Access with rapid review, DOI, and global visibility.
Double-Blind CrossRef DOI Discoverable
Submit Manuscript Membership